Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Gross Profit (2021 - 2025)

Goldenwell Biotech's Gross Profit history spans 5 years, with the latest figure at $25000.0 for Q3 2025.

  • For Q3 2025, Gross Profit changed N/A year-over-year to $25000.0; the TTM value through Sep 2025 reached $62415.0, up 43546.85%, while the annual FY2024 figure was $64.0, 90.39% down from the prior year.
  • Gross Profit reached $25000.0 in Q3 2025 per GWLL's latest filing, down from $37500.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $37500.0 in Q2 2025 to a low of -$85.0 in Q4 2024.
  • Average Gross Profit over 5 years is $7023.6, with a median of $646.0 recorded in 2021.
  • Peak YoY movement for Gross Profit: plummeted 216.44% in 2024, then surged 53471.43% in 2025.
  • A 5-year view of Gross Profit shows it stood at $2578.0 in 2021, then surged by 793.25% to $23028.0 in 2022, then plummeted by 99.68% to $73.0 in 2023, then tumbled by 216.44% to -$85.0 in 2024, then skyrocketed by 29511.76% to $25000.0 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Gross Profit are $25000.0 (Q3 2025), $37500.0 (Q2 2025), and -$85.0 (Q4 2024).